ISRCTN87639321已完成不适用
The effects of bisphosphonates on disease activity and bone status in ankylosing spondylitis (BIAS)
Royal National Hospital for Rheumatic Diseases (UK)0 个研究点目标入组 180 人开始时间: 2005年5月23日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age > 21, stable dose of non-steroidal anti-inflammatory drug (NSAID) for last four weeks. Need to fulfil New York Criteria for AS.
排除标准
- •1. Systemic steroids for the last three months
- •2. Bisphosphonates in the last 12 months
- •3. Oesophageal disease or active peptic ulcer
- •4. Unable to give informed consent
- •5. Known Paget's Disease
- •6. Renal disease with creatinine >150 mmol/l, hypercalcaemia, osteomalacia, inflammatory bowel disease, known malignancy and reduced life expectancy <2 years
研究者
相似试验
招募中
不适用
The Effect of Bisphosphonates on the Immune System in Adults With OsteoporosisImmune systemMusculoskeletal - OsteoporosisInflammatory and Immune System - Other inflammatory or immune system disordersOsteoporosisACTRN12614000300673Bone Research Group, Garvan Institute of Medical Research44
已完成
不适用
Effect of treatment with an oral bisphosphonate on markers of bone formation and bone resorption in adults with alkpatonuriaISRCTN12672997niversity Medical Centre Utrecht (UMCU) (The Netherlands)6
已完成
2 期
Comparison of the effect of Bisphosphonate on the prevention of type 2 diabetes among Osteopenic menopause prediabetes women and Referred to Isfahan Endocrine and Metabolism Research Center.Prediabetes.Impaired glucose tolerance, Menopausal and other perimenopausal disorders, Postmenopausal osteoporosisR73, N95,IRCT2016101530309N1Vice chancellor for research, Isfahan University of Medical Sciences60
进行中（未招募）
不适用
The impact of local bisphosphonate treatment on prosthetic fixatioOsteoarthritis of the hip joint treated with total hip replacementEUCTR2009-014414-98-SEDepartment of Orthopaedic Surgery University Hospital Linköping
进行中（未招募）
不适用
Effects of drug treatment with bisphosphonates (zoledronic acid) in the prevention of skeletal events in breast cancer patients with osteoporosis. Significant correlation with some biological parameters - NDMedDRA version: 12.1Level: LLTClassification code 10057654Term: Breast cancer femaleBreast cancerEUCTR2010-019216-20-ITAZIENDA OSPEDALIERO UNIVERSITARIA DI CAGLIARI